Key takeaways: GLP-1 medications are primarily used for weight loss, but are increasingly being explored in relation to PCOS and perimenopause Early evidence (mainly in women with obesity and PCOS) suggests GLP-1s may improve insulin resistance and support more regular menstrual cycles and ovulation There is currently limited research on how GLP-1 medications affect periods, fertility, PMS, or menopause symptoms in the wider population Period tracking apps like Clue may help users monitor cycle and symptom changes while using GLP-1 medications 1
Documentation of metabolic dysfunction (insulin resistance, prediabetes, lipid abnormalities) improves approval odds significantly
The Glutathione IV is an antioxidant-focused infusion that delivers glutathione, vitamin C, zinc, and L-carnitine directly into the bloodstream
Steven H
Great Stride in Sema's mechanistic aspects
Liraglutide was another agent in the class showing a similar mortality reduction but to a lesser degree compared to oral semaglutide